Search Results
Oncotype DX Testing and the TAILORx Trial
Dr Richard De Boer discusses the TAILORx trial of OncotypeDX
Oncotype DX Breast Recurrence Score Assay after TAILORx and RxPONDER: What’s Next?
TAILORx: an update incl 12-year event rates in woman with ER+ lymph node-negative breast cancer
Oncotype DX Test for Breast Cancer: How it Differs from Tumor DNA Sequencing and Why it's Used 👀
Role of the Oncotype DX Breast Recurrence Score Test
How Is The Oncotype DX Test Used In Lymph Node Positive Patients? - Dr. Jay Harness
Oncotype DX for Early-stage Breast Cancer
Outcomes Matter -- oncotype DX®
Less Chemotherapy for Breast Cancer: The TAILORx Results
Oncotype DX in Early Stage Breast Cancer
Steve Shak, ASCO 2020: The Oncotype DX Breast Recurrence Score® Test